Treatment

The Masonic Cancer Center, University of Minnesota brings together more than 500 U faculty and researchers from dozens of fields who are conquering cancer from many angles. Recent Masonic support has fueled pioneering research on some of the most promising cancer therapies in the field, accelerating a shift from conventional therapies to more targeted and personalized approaches. 

Featured stories

Angela Mortari
One of the biggest obstacles to creating new cancer therapies is the time it takes to move them from lab to person.
Balbo Lab
In addition to causing side effects such as vomiting or hair loss, chemotherapy is thought to play a significant role in how patients respond to... Read more
David Stenehjem
With a five-year survival rate of 27 percent, acute myeloid leukemia (AML), which starts in bone marrow and quickly moves into blood, is one of the... Read more
Rita P
While acute myeloid leukemia (AML) is one of the most common types of leukemia in adults, there is currently not a cure. That’s why researchers at... Read more
William Pomerantz
An exciting evolution in cancer research has been the development of epigenetic therapies, which reprogram cancer cells to adopt a healthier state.
Armin Rashini
In patients with acute myeloid leukemia (AML) undergoing intense chemotherapy, as well as those undergoing stem cell transplantation, bloodstream... Read more
Manish Patel
Caring for cancer patients inspired Manish Patel, D.O., to become a researcher.
Tanya Freedman
Macrophage cells play an important role in the immune system by finding and killing invaders, but breast tumors can reprogram them to support tumor... Read more
Brian Betts
As a child, Brian Betts, M.D., benefitted firsthand from the exceptional health care provided at the University of Minnesota and Children’s Hospital... Read more
Beau Webber
Beau Webber, Ph.D., part of the U’s pediatrics faculty, marvels that our own immune cells can be reprogrammed to fight advanced cancers. That... Read more
Justin Drake
Improved screening, earlier diagnosis, and new treatments have increased the prognosis for many, but some develop advanced prostate cancer that no... Read more
Ingunn Strommes
As a predoctoral fellow at the National Institutes of Health, Ingunn Stromnes, Ph.D., became captivated by how the immune system is essential for... Read more
David Potter
With Masonic support, David Potter, M.D., Ph.D., a hematology, oncology, and transplantation faculty member, is working to improve outcomes for women... Read more
Anja Bielinsky
Cancer is a genetic disease, occurring when inherited or environmental factors corrupt the DNA in cells. Although scientists have made strides in... Read more